Results 1 to 10 of about 4,222 (186)

Somatic mosaicism for a novel PDHA1 mutation in a male with severe pyruvate dehydrogenase complex deficiency

open access: yesMolecular Genetics and Metabolism Reports, 2014
Pyruvate dehydrogenase complex (PDC) deficiencies are mostly due to mutations in the X-linked PDHA1 gene. Males with hemizygous PDHA1 mutations are clinically more severely affected, while those with mosaic PDHA1 mutations may manifest milder phenotypes.
Jirair K Bedoyan   +2 more
exaly   +6 more sources

Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction [PDF]

open access: yesScientific Reports
Acute myocardial infarction (AMI) is a threat to health, with high morbidity and mortality, posing a challenge to the public health system. This study aimed to explore the efficacy and potential targets of Astragaloside IV (AS-IV) combined with ...
Du Feng, Feng Du, Zhenqiu Yu
exaly   +5 more sources

Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer

open access: yesFrontiers in Pharmacology, 2022
Recent studies have proposed that pyruvate dehydrogenase E1 component subunit alpha (PDHA1), a cuproptosis-key gene, is crucial to the glucose metabolism reprogram of tumor cells.
Langmei Deng, Anqi Jiang, Xiaoji Peng
exaly   +5 more sources

Conditional Knockout of Pdha1 in Mouse Hippocampus Impairs Cognitive Function: The Possible Involvement of Lactate [PDF]

open access: yesFrontiers in Neuroscience, 2021
Background and Purpose: Neurodegenerative diseases are associated with metabolic disturbances. Pyruvate dehydrogenase E1 component subunit alpha (PDHA1) is an essential component in the process of glucose metabolism, and its deficiency exists in various ...
Tingting Bi, Bi Tingting
exaly   +5 more sources

The potential impact of GLS and PDHA1 on tumor immunity and immunotherapy response in LUSC. [PDF]

open access: yesFront Genet
BackgroundLung squamous cell carcinoma (LUSC), a therapeutically challenging non-small cell lung cancer (NSCLC) subtype with a poor prognosis, exhibits heterogeneous responses to immunotherapy.
Ling T, Wu J, Xiaohao L.
europepmc   +4 more sources

SIRT3 regulates PDHA1 acetylation in HUVECs to modulate inflammation and pyroptosis under clinorotation. [PDF]

open access: yesiScience
Summary: Microgravity-induced endothelial inflammation contributes to cardiovascular dysfunction in astronauts, but the metabolic mechanisms involved are not fully defined. Sirtuin-3 (SIRT3), a mitochondrial deacetylase, regulates cellular metabolism and
Jiang M   +9 more
europepmc   +4 more sources

PDHA1 enhances resistance to ferroptosis in anoikis-resistant prostate cancer by upregulating AIFM2. [PDF]

open access: yesCell Death Discov
Cells that detach from the extracellular matrix (ECM) undergo various forms of cell death, including ferroptosis. Previous studies have demonstrated that prostate cancer (PCa) cells undergo ferroptosis following ECM detachment, and resistance to ...
Cong Y   +10 more
europepmc   +4 more sources

Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. [PDF]

open access: yesNPJ Precis Oncol
Sarcomas are aggressive, immunologically cold tumors with limited benefit from immune-checkpoint blockade (ICB). Through integrated multi-omics, functional, and clinical analyses, we identify pyruvate dehydrogenase alpha 1 (PDHA1)—a cuproptosis-linked ...
Qin H   +10 more
europepmc   +2 more sources

Mitochondrial PDHA1 acetylation orchestrates lactate-dependent epigenetic reprogramming to promote fibrosis via NUAK2. [PDF]

open access: yesCell Mol Life Sci
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with few effective treatment options. While metabolic reprogramming has been associated with IPF, the precise mechanisms connecting mitochondrial metabolic dysfunction to ...
Wang Y   +11 more
europepmc   +2 more sources

PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer. [PDF]

open access: yesCell Death Dis
Acquired resistance to enzalutamide (Enz) presents a significant challenge in castration-resistant prostate cancer (CRPC), and overcoming this resistance remains an unmet clinical need.
Zhuang R   +12 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy